Viking Therapeutics (VKTX) announced that results from the company’s Phase 2b clinical trial of VK2809, the company’s novel liver-selective thyroid hormone receptor beta agonist, in patients ...
Data breaches are the worst nightmare for many companies. It is often rightfully listed among top concerns of company leaders. In the third quarter of 2024, 422.61 million data records were leaked ...
This advertisement has not loaded yet, but your article continues below. The franchisee of the Second Cup locations at the Jewish General Hospital was filmed telling pro-Israel protesters: 'The ...